Chun Xu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Research Progress and Application Prospects of Saliva-Based Point-of-Care Testing Technologies
Journal: Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation
Published: June 24, 2026
Triple oral therapy with metformin, DPP-4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025).
Journal: Diabetes, obesity & metabolism
Published: September 23, 2025
Gitelman syndrome: diagnostic challenges and therapeutic strategies.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: May 05, 2025
From bench to bed: deep insights the tacrolimus-induced diabetes and gut microbiota dysbiosis.
Journal: European journal of medical research
Published: April 03, 2025
Prevalence of obstructive sleep apnea syndrome in hospitalized patients with type 2 diabetes in Beijing, China.
Journal: Journal of diabetes investigation
Published: March 28, 2022
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS).
Journal: Science bulletin
Published: February 27, 2020
The effects of short-term treatment of microcystin-LR on the insulin pathway in both the HL7702 cell line and livers of mice.
Journal: Environmental toxicology
Published: October 17, 2019
Impact of baseline characteristics on glycemic effects of add-on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus.
Journal: Journal of diabetes investigation
Published: July 30, 2019
Microcystin-LR exposure disrupts the insulin signaling pathway in C2C12 mice muscle cell line.
Journal: Environmental toxicology
Published: June 24, 2019
Last Updated: 09/26/2026